The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46.
United Natural Foods, Inc.
UNFI · the NYSE · USD · Market cap $2.9B · 25,600 employees
United Natural Foods, Inc., together with its subsidiaries, engages in the distribution of natural, organic, specialty, produce, and conventional grocery and non-food products in the United States and Canada.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price48.70 USD at the 13 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 13 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 1.23)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $60.90 to $97.40, base estimate $61.00 (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.23, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
United Natural Foods, Inc. holds its Distribution at $48.70. The statistical read favours the sellers, held for 184 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 184 days |
| Price at the screen | $48.70 |
| Valuation | 36.04 trailing · 11.89 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.08 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 45.44% | Below 33% | Interest-bearing debt is 45.4% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.08% | Below 49% | Money owed to the company is 14.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.01% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
United Natural Foods,'s business is in a permissible area, but its interest-bearing debt is about 45% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when UNFI's ethical verdict changes
Today UNFI does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 20% discount to our $61.00 fair value.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 20.2% discount to the base estimate.
Third-party analyst targets: 8 covering, consensus Buy. The average target sits +6% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $61.00, with a range of $60.90 to $97.40, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFood Distributor With Shrinking Sales and Losses
Picture a wholesaler shifting boxes of organic produce and staples from warehouse to supermarket shelves. United Natural Foods handles that job across the US and Canada, yet revenue is already falling 4 percent and both profit margin and return on equity sit below zero. The shares trade above our fair value with a negative margin of safety, so we see no opportunity here.
Analysts still rate the stock a buy with a median target near the current price, but forward earnings sit at 15.3 times while the business posts no growth and no profits. Ethical checks clear, yet the numbers show a company unable to cover its cost of capital or expand its top line.
Cyclical food distribution can mask problems until volumes drop further or working capital tightens. Without visible improvement in margins or revenue, the gap between price and value is likely to widen rather than close. Analysis, not advice.
| Forward P/E | 11.9xreasonably valued |
| Trailing P/E | 36.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.34 |
| EPS, forward | 4.06 |
| Revenue growth | -0.7%revenue is shrinking |
| Profit margin | 0.3%barely profitable |
| Return on equity | 5.3%a modest return on shareholder capital |
| FCF yield | 14.66% |
| Debt to equity | 1.87a meaningful debt load worth watching |
| Current ratio | 1.29adequate liquidity, worth monitoring |
| Beta | 1.08moves a little more than the market |
| Short interest, float | 0.08% |
| 52-week range | 30.91 - 57.02 |
| Market cap | $2.9B |
| Employees | 25,600 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeUNFI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (8 analysts) rates it none, with a mean price target of $46. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- United Natural Foods to Release First Quarter Fiscal 2027 Results on December 8, 2026 Yahoo Finance · 7d ago
- What Is Behind The Move In Sysco Stock? Yahoo Finance · 13d ago
- What Sprout Social (SPT) Said on Its Q3 Earnings Call Yahoo Finance · 13d ago
- Natural Food Stocks to Gain Momentum as Health Trends Drive Demand Yahoo Finance · 21d ago
- United Natural Foods (UNFI): buy, sell, or hold post Q2 earnings? Yahoo Finance · 21d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $52.27 | -3.2% | · | $968 | -3.2% |
| 2 months | $46.26 | +9.4% | · | $1,094 | +9.4% |
| 3 months | $40.34 | +25.4% | · | $1,254 | +25.4% |
| 6 months | $32.51 | +55.6% | · | $1,556 | +55.6% |
| 1 year | $23.30 | +117.1% | · | $2,171 | +117.1% |
| 2 years | $14.30 | +253.8% | · | $3,538 | +253.8% |
| 3 years | $20.44 | +147.5% | · | $2,475 | +147.5% |
| 5 years | $35.41 | +42.9% | · | $1,429 | +42.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever UNFI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.